Fuan Pharmaceutical (300194.SZ) announced that Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd. (“Bosheng Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a chemical ingredient marketing application approval notice issued by the State Drug Administration. The name of the ingredient is midazolam hydrochloride, which is mainly used for pre-anesthetic administration, induction and maintenance of general anesthesia, adjuvant medication, diagnostic or therapeutic procedures during local anesthesia (such as cardiovascular radiography, cardiac arrhythmia, bronchoscopy, gastrointestinal endoscopy, etc.) Sedation, ICU patient sedation.